AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • November 12th, 2013 • Pernix Therapeutics Holdings, Inc. • Pharmaceutical preparations • California
This Amended and Restated License Agreement (“Agreement”) is made and entered into as of September 15, 2010 (the “Agreement Date”), and is deemed effective as of the Effective Date (hereinafter defined), by and between Somaxon Pharmaceuticals, Inc. (“Somaxon”) and ProCom One, Inc. (“ProCom One”).
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • August 16th, 2010 • Robertson Global Health Solutions Corp • Investors, nec • Michigan
This Amendment and Restated License Agreement (“Agreement”), effective as of April 28, 2010 (the “Effective Date”), is made by and between Vanahab Health Diagnostics, LLC, a Nevada limited liability company, having an office at 4215 Fashion Square Boulevard, Suite 3, Saginaw, Michigan 48603 (hereinafter “Licensor”) and NxOpinion LLC, a Nevada limited liability company, having its principal place of business at 4215 Fashion Square Boulevard, Suite 3, Saginaw, Michigan 48603 (hereinafter “Licensee”).
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • January 5th, 2009 • Colony Resorts LVH Acquisitions LLC • Hotels & motels • Nevada
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into as of January 1, 2009 (the “Effective Date”) by and between HLT EXISTING FRANCHISE HOLDING LLC, a Delaware limited liability company (“Hilton”), and COLONY RESORTS LVH ACQUISITONS, L.L.C., a Nevada limited liability company (“Resorts”).
AMENDED AND RESTATED license agreementAmended and Restated License Agreement • October 1st, 2021 • Lucid Diagnostics Inc. • Surgical & medical instruments & apparatus • Ohio
This Amended and Restated License Agreement (hereinafter “Agreement”) entered into as of this 23rd day of August 2021 (“A&R Effective Date”) by and between Case Western Reserve University, an Ohio non-profit corporation, having a principal place of business at 10900 Euclid Avenue, Cleveland, Ohio 44106 (“CWRU”) and Lucid Diagnostics Inc., a Delaware corporation, having a principal place of business at One Grand Central Place, Suite 4600, New York, NY 10165 (“Licensee”). Upon the A&R Effective Date, this Agreement shall amend and restate in its entirety the Existing License Agreement, which existing agreement shall thereafter be of no force and effect.
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • August 6th, 2018 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) is made effective as of the 2nd day of August, 2018 (the “Effective Date”), by and between Gemphire Therapeutics Inc., a Delaware corporation with offices at 17199 N. Laurel Park Dr., Suite 401, Livonia, MI 48152 (“LICENSEE”), and Pfizer Inc., a corporation organized and existing under the laws of Delaware with offices at 235 East 42nd Street, New York, NY 10017 (“PFIZER”). LICENSEE and PFIZER may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties.”
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • March 19th, 2010 • POSITIVEID Corp • Communications equipment, nec • New York
Effective this 26th day of February, 2010 (the “EFFECTIVE DATE”), PositiveID Corporation (formerly known as VeriChip Corporation), a corporation organized and existing under the laws of Delaware having its principal office at 1690 South Congress Avenue, Suite 200, Delray Beach, FL, 33445, and its AFFILIATES (hereinafter “LICENSEE”) and RECEPTORS LLC, a corporation organized and existing under the laws of the State of Minnesota, having its principal office at Suite 510, 1107 Hazeltine Blvd., Chaska, MN 55318, U.S.A., and its AFFILIATES, as defined below, (hereinafter, collectively, “RECEPTORS”) agree, for the consideration set forth in Section 2.1 of this Agreement, to amend and restate the License Agreement, dated October 6, 2009, by and between LICENSEE and RECEPTORS as follows:
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • January 5th, 2016 • Independence Bancshares, Inc. • National commercial banks • New York
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”), dated as of January 4, 2016 (the “Effective Date”), by and between MPIB Holdings, LLC, a Delaware limited liability company (“MPIB”), and Independence Bancshares Inc., a South Carolina corporation (“IB”, and each of MPIB and IB, a “Party” and collectively the “Parties”). This Agreement amends and completely restates that certain license agreement between the Parties dated May 14, 2015 (the “Original License Agreement”).
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • January 28th, 2010 • Neomedia Technologies Inc • Services-computer integrated systems design • New York
This Amended and Restated License Agreement (the “Agreement”) is entered into as of the last date of execution below (the “Effective Date”) by and between NeoMedia Technologies, Inc. (“NeoMedia”), a Delaware corporation with a principal place of business at Suite 500, Two Concourse Parkway, Atlanta, Georgia, 30328 and NeuStar, Inc. (“Neustar”), a Delaware corporation, with a principal place of business at 46000 Center Oak Plaza, Sterling, VA 20166 (each a “Party” and collectively the “Parties”).
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • December 6th, 2018 • Predictive Technology Group, Inc. • Wholesale-hardware & plumbing & heating equipment & supplies
THIS AMENDED AND RESTATED LICENSE AGREEMENT (the "Agreement") is effective as of August 1, 2016 (the "Effective Date") by and between Juneau Biosciences, LLC (hereinafter "LICENSOR"), a Utah corporation having its principal place of business at 2749 East Parleys Way, Suite 210, Salt Lake City, UT 84109, and Predictive Therapeutics, LLC (hereinafter "LICENSEE"), a Utah limited liability company having its principal place of business at 2749 Parleys Way, Suite 101, Salt Lake City, Utah 84109 (collectively, the "Parties").
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • September 22nd, 2014 • Royal Mines & Minerals Corp • Metal mining • Nevada
ROYAL MINES AND MINERALS CORP., a Nevada corporation, having its principal place of business located at 2580 Anthem Village Dr., Henderson, NV 89052;
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • March 12th, 2021 • Colorado
[WHEREAS, with Licensor’s consent, Original Licensee assigned the Original License Agreement to Licensee pursuant to a Consent to Assignment Agreement dated among Licensor, Original Licensee and Licensee.]
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • May 31st, 2023 • Denali SPAC Holdco, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”), which is amended and restated as of February 16, 2018, is entered into between Cerevast Medical, Inc., a Delaware corporation (“Cerevast”), and Doheny Eye Institute, a California nonprofit public benefit corporation (“Doheny”).
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • March 2nd, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Amended and Restated License Agreement (this “Agreement”) is made effective as of March 7, 2011 (the “Effective Date”) by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 26 Landsdowne Street, Cambridge, MA 02139 (“ARIAD”), and Bellicum Pharmaceuticals, Inc., a Delaware corporation with a place of business at 6400 Fannin St., Suite 2300, Houston, TX 77030 (“Bellicum”). ARIAD and Bellicum are each hereafter referred to individually as a “Party” and together as the “Parties”.
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • December 11th, 2021 • California
THIS AGREEMENT (“Agreement”), dated as of November 1, 2006, and amended and restated effective May 21, 2012 (“Restatement Effective Date”), is entered into by Sony Pictures Television Canada, a branch of Columbia Pictures Industries Inc., a Delaware corporation (“Licensor”), and Shaw Cablesystems G.P., a general partnership organized and existing under the laws of Alberta (“Licensee”). For good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • September 7th, 2006 • Auriga Laboratories, Inc. • Services-business services, nec • Delaware
This Amended and Restated License Agreement (the “Agreement”) is entered into and made effective as of this 6th day of September 2006, (the “Effective Date”) by and between CORNERSTONE BIOPHARMA, INC., a Nevada corporation (“Cornerstone”), and AURIGA LABORATORIES, INC., a Delaware corporation (“Auriga”) collectively the “Parties.”
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • July 10th, 2024 • California
THIS AGREEMENT (“Agreement”), dated as of November 1, 2006, and amended and restated effective [●], 2010, is entered into by Sony Pictures Television Canada, a branch of Columbia Pictures Industries Inc., a Delaware corporation (“Licensor”), and Shaw Cablesystems G.P., a general partnership organized and existing under the laws of Alberta (“Licensee”). For good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • May 14th, 2012 • WisdomTree Investments, Inc. • Commodity contracts brokers & dealers • New York
THIS AGREEMENT, dated as of March 1, 2012 (“Effective Date”), is made by and between WisdomTree Investments, Inc., a Delaware corporation, having its principal place of business at 380 Madison Avenue, 21st Floor, New York, NY 10017 (“Licensor”), and WisdomTree Trust, a Delaware business trust, having its principal place of business at 380 Madison Avenue, 21st Floor, New York, NY 10017 (“Licensee”) and hereby amends and restates the prior agreement between the parties dated March 21, 2006.
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • March 11th, 2021 • Spero Therapeutics, Inc. • Pharmaceutical preparations
This AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) , effective as of January 15, 2021 (the “Amendment Effective Date”), is entered into by and among Everest Medicines II Limited, a company incorporated under the laws of the Cayman Islands (“Everest”) having its registered office at Vistra (Cayman) Limited, P. O. Box 31119, Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1 – 1205, Cayman Islands; Spero Therapeutics, Inc., a Delaware corporation (“Spero”) having its principal place of business at 675 Massachusetts Avenue, 14th Floor, Cambridge, Massachusetts, 02139; and, solely for purposes of Section 3.3(e) (with respect to the SPR741 Option), Spero Potentiator, Inc., a Delaware corporation (“Potentiator”) having its principal place of business at 675 Massachusetts Avenue, 14th Floor, Cambridge, Massachusetts, 02139. Everest, Spero and Potentiator are referred to individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED LICENSE AGREEMENTAmended and Restated License Agreement • May 5th, 2020 • California
Subject to the provisions in the License Agreement, Licensee shall perform the following work (collectively, "Site Work"): [insertdescriptfon ofSite Workwhen approved].
